AU2002360774A1 - 4-substituted fused heteropyrimidines and fused hetero-4-pyrimidones - Google Patents

4-substituted fused heteropyrimidines and fused hetero-4-pyrimidones

Info

Publication number
AU2002360774A1
AU2002360774A1 AU2002360774A AU2002360774A AU2002360774A1 AU 2002360774 A1 AU2002360774 A1 AU 2002360774A1 AU 2002360774 A AU2002360774 A AU 2002360774A AU 2002360774 A AU2002360774 A AU 2002360774A AU 2002360774 A1 AU2002360774 A1 AU 2002360774A1
Authority
AU
Australia
Prior art keywords
fused
heteropyrimidines
pyrimidones
hetero
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002360774A
Other versions
AU2002360774A8 (en
Inventor
Donald E. Bierer
William J. Scott
Andreas Stolle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Corp
Original Assignee
Bayer AG
Bayer Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG, Bayer Corp filed Critical Bayer AG
Publication of AU2002360774A1 publication Critical patent/AU2002360774A1/en
Publication of AU2002360774A8 publication Critical patent/AU2002360774A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
AU2002360774A 2001-12-28 2002-12-27 4-substituted fused heteropyrimidines and fused hetero-4-pyrimidones Abandoned AU2002360774A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34415501P 2001-12-28 2001-12-28
US60/344,155 2001-12-28
PCT/US2002/041428 WO2003057149A2 (en) 2001-12-28 2002-12-27 4-substituted fused heteropyrimidines and fused hetero-4-pyrimidones

Publications (2)

Publication Number Publication Date
AU2002360774A1 true AU2002360774A1 (en) 2003-07-24
AU2002360774A8 AU2002360774A8 (en) 2003-07-24

Family

ID=23349286

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002360774A Abandoned AU2002360774A1 (en) 2001-12-28 2002-12-27 4-substituted fused heteropyrimidines and fused hetero-4-pyrimidones

Country Status (2)

Country Link
AU (1) AU2002360774A1 (en)
WO (1) WO2003057149A2 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1651652B1 (en) * 2003-07-24 2006-12-27 Bayer Pharmaceuticals Corporation Substituted tetrahydrobenzothienopyrimidinamine compounds useful for treating hyper-proliferative disorders
US8637528B2 (en) 2007-03-27 2014-01-28 Omeros Corporation Use of PDE7 inhibitors for the treatment of movement disorders
EP2139475B1 (en) 2007-03-27 2014-12-17 Omeros Corporation PDE7 inhibitors for use in the treatment of movement disorders
WO2009104026A1 (en) * 2008-02-19 2009-08-27 Vichem Chemie Kutató Kft Tricyclic benzo[4,5]thieno-[2,3-d]pyrimidine-4-yl-amin derivatives, their salts, process for producing the compounds and their pharmaceutical use
US9220715B2 (en) 2010-11-08 2015-12-29 Omeros Corporation Treatment of addiction and impulse-control disorders using PDE7 inhibitors
KR20160105948A (en) 2010-11-08 2016-09-07 오메로스 코포레이션 Treatment of addiction and impulse-control disorders using pde7 inhibitors
EP3239154A1 (en) 2011-01-10 2017-11-01 Nimbus Iris, Inc. Irak inhibitors and uses thereof
US9732083B2 (en) 2011-03-15 2017-08-15 Merck Sharp & Dohme Corp. Tricyclic gyrase inhibitors
CN104582705A (en) 2012-01-10 2015-04-29 林伯士艾瑞斯公司 IRAK inhibitors and uses thereof
WO2014011902A1 (en) 2012-07-11 2014-01-16 Nimbus Iris, Inc. Irak inhibitors and uses thereof
CN104902959A (en) 2012-07-11 2015-09-09 林伯士艾瑞斯公司 Irak inhibitors and uses thereof
ES2889757T3 (en) * 2012-09-06 2022-01-13 Plexxikon Inc Compounds and methods for the modulation of kinases and indications for these
US9175007B2 (en) 2013-01-10 2015-11-03 Nimbus Iris, Inc. IRAK inhibitors and uses thereof
CN106232122A (en) 2013-09-27 2016-12-14 林伯士艾瑞斯公司 IRAK inhibitor and its purposes
WO2023212019A1 (en) * 2022-04-28 2023-11-02 Enanta Pharmaceuticals, Inc. Pyrimidinone-containing 17-beta-hydroxysteroid dehydrogenase type 13 inhibitors
WO2024038090A1 (en) 2022-08-18 2024-02-22 Mitodicure Gmbh Use of substituted benzoxazole and benzofuran compounds for the treatment and prevention of diseases associated with chronic fatigue, exhaustion and/or exertional intolerance

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5654307A (en) * 1994-01-25 1997-08-05 Warner-Lambert Company Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
US6140332A (en) * 1995-07-06 2000-10-31 Novartis Ag Pyrrolopyrimidines and processes for the preparation thereof

Also Published As

Publication number Publication date
WO2003057149A2 (en) 2003-07-17
AU2002360774A8 (en) 2003-07-24
WO2003057149A3 (en) 2003-12-18
WO2003057149B1 (en) 2004-02-19

Similar Documents

Publication Publication Date Title
AU2002315389A1 (en) Novel pyrazolo-and pyrrolo-pyrimidines and uses thereof
AU2002360561A1 (en) 4-substituted piperidines, and methods of use thereof
AU2002315388A1 (en) Novel phenylamino-pyrimidines and uses thereof
AU2002305523A1 (en) Dioxanes and uses thereof
AU2002360774A1 (en) 4-substituted fused heteropyrimidines and fused hetero-4-pyrimidones
AU2002236006A1 (en) Radiometers
AU2002343312A1 (en) Two fixed-beams tx-diversity
AU2002366513A1 (en) Scoring methodology
AU2002357891A1 (en) Dtat fusion toxin
AU2002359694A1 (en) Compounds and methods
AU2001290641A1 (en) Substituted fused pyrroleimines and pyrazoleimines
AU2002365354A1 (en) Case and case holder
AU2002338989A1 (en) Substituted C-furan-2-yl-methylamine and C-thiophen-2-yl-methylamine derivatives
AUPR977601A0 (en) Defective entities and uses therefor
AU2002321479A1 (en) Thermographic metthod
AU2002317510A1 (en) Spectacles and spectacles set
AU2002322281A1 (en) Novel quinolines and uses thereof
AU2002312554A1 (en) Novel quinolines and uses thereof
AU2001298019A1 (en) Thermal fuse
AU2002322287A1 (en) Novel idolinones and uses thereof
AU2002312558A1 (en) Novel pyridopyrimidones and uses thereof
AU2002304466A1 (en) Sintered wellscreen
AU2002321166A1 (en) Substituted 1-aryl-but-3-enylamine and 1-ary-but-2-enylamine compounds
AU2002309392A1 (en) Modified oxide
AU2002356117A1 (en) Novel diarylalkene derivatives and novel diarylalkane derivatives

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase